HER-2/neu expression in archival non small cell lung carcinomas using FDA-approved Hercep test

Anticancer Research

Volumn 20, Issue 3 B, 2000, Pages 2091-2096

  Scheurle, Daniela ^a   Jahanzeb, Mohammad ^b   Aronsohn, Richard S ^c   Watzek, Laura ^c   Narayanan, Ramaswamy ^a  

^a FLORIDA ATLANTIC UNIVERSITY   (United States)

^b Compreh Cancer Care Specialists B ^*  (United States)

^c Boca Raton Community Hospital   (United States)

Author keywords

Adenocarcinomas; Differentiation; Gene amplification; Herceptin; Immunohistochemistry

Indexed keywords

ANTIBODY; EPIDERMAL GROWTH FACTOR RECEPTOR; GLYCOPROTEIN; ONCOPROTEIN; PARAFFIN; TRASTUZUMAB;

ARTICLE; DIAGNOSTIC TEST; FOOD AND DRUG ADMINISTRATION; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; ONCOGENE NEU; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; SQUAMOUS CELL CARCINOMA; TUMOR DIFFERENTIATION;

ADENOCARCINOMA; ANTIBODIES, MONOCLONAL; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; EVALUATION STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, ERBB-2; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; NEOPLASM PROTEINS; PARAFFIN EMBEDDING; REAGENT KITS, DIAGNOSTIC; RECEPTOR, ERBB-2; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 0033869769     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Coussens L, Yang-Feng TL, Liao YC, Chen E, Gray A, McGrath J, Seeburg PH, Libermann TA, Schlessinger J, Francke U and et al: Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 230: 1132-1139, 1985.
2. King CR, Kraus MH and Aaronson SA: Amplification of a novel v-erhB-related gene in a human mammary carcinoma. Science 229: 974-976, 1985.
3. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A and Press MF: Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244: 707-712, 1989.
4. Kern JA, Schwartz DA, Nordberg JE, Weiner DB, Greene MI, Torney L and Robinson RA: p185neu Expression in human lung adenocarcinomas predicts shortened survival. Cancer Res 50: 5184-5191, 1990.
5. Weiner DB, Nordberg J, Robinson R, Nowell PC, Gazdar A, Greene MI, Williams WV, Cohen JA and Kern JA: Expression of the neu gene-encoded protein (P185neu) in human non-small cell carcinomas of the lung. Cancer Res 50: 421-425, 1990.
6. Schneider PM, Hung MC, Chiocca SM, Manning J, Zhao X, Fang K, and Roth JA: Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer. Cancer Res 49: 4968-4971, 1989.
7. Veale D, Ashcroft T, Marsh C, Gibson GJ, and Harris AL: Epidermal growth factor receptors in non-small cell lung cancer. Br J Cancer 55: 513-516, 1987.
8. Simes RJ: Risk-benefit relationships in cancer clinical trials: the ECOG experience in non-small-cell lung cancer. J Clin Oncol 3: 462-472, 1985.
9. Jahanzeb M and Ihde DC: Chemotherapy of Lung Cancer. In The Chemotherapy Source Book. 2nd Edition. MC Perry, Ed. Williams & Wilkins, Philadelphia, pp 1103-1123, 1995.
10. Norton L, Slamon D, Leyland-Jones B, Wolter J, Fleming T, Eirmann W, Baselga J, Mendelsohn J, Bajamonde A, Ash M and Shak S: Overall survival (OS) advantage ti simultaneous chemotherapy (CRx) plus the humanized anti-HER2 monoclonal antibody Herceptin (H) in HER2-overexpressing (HER2+) metastatic breast cancer (MBC). Proceedings of ASCO 18: 483, 1999.
11. Kern JA, Robinson RA, Gazdar A, Torney L and Weiner DB: Mechanisms of p185Her2 expression in human non-small cell lung cancer cell lines. Am J Respir. Cell Mol Biol 6: 359-363, 1992.
12. Elek J, Pinzon W, Park KH and Narayanan R: Relevant genomics of neurotensin receptor in cancer. Anticancer Res. (In Press).
13. Jacobs TW, Gown AM, Yaziji H, Barnes MJ and Schnitt SJ: Specificity of HercepTest in determining HER-2/neu status of breast cancers using the United States Food and Drug Administration-approved scoring system. J Clin Oncol 17: 1983-1987, 1999.
14. Cohen JA, Weiner DB, More KF, Kokai Y, Williams WV, Maguire HC, Jr., LiVolsi VA and Greene MI: Expression pattern of the neu (NGL) gene-encoded growth factor receptor protein (p185neu) in normal and transformed epithelial tissues of the digestive tract. Oncogene 4: 81-88, 1989.
15. Press MF, Hung G, Godolphin W and Slamon DJ: Sensitivity of HER-2/neu antibodies in archival tissue samples: potential source of error in immunohistochemical studies of oncogene expression. Cancer Res 54: 2771-2777, 1994.
16. Wingo PA, Ries LA, Giovino GA, Miller DS, Rosenberg HM, Shopland DR, Thun MJ and Edwards BK: Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. J Natl Cancer Inst 91: 675-690, 1999.
17. Wong AJ, Ruppert JM, Eggleston J, Hamilton SR, Baylin SB, and Vogelstein B: Gene amplification of c-myc and N-myc in small cell carcinoma of the lung. Science 233: 461-464, 1986.
18. Griffin CA and Baylin SB: Expression of the c-myb oncogene in human small cell lung carcinoma. Cancer Res 45: 272-275, 1985.
19. Rodenhuis S, van de Wetering ML, Mooi WJ, Evers SG, van Zandwijk N and Bos JL: Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung. N. Engl J Med 317:929-935, 1987.
20. Jacobs TW, Gown AM, Yaziji H, Barnes MJ and Schnitt SJ: Comparison of fluorescence in situ hybridization and immunohistochemistry for the evaluation of HER-2/neu in breast cancer. J Clin Oncol 17: 1974-1982, 1999.
21. Kay EW, Walsh CJ, Cassidy M, Curran B and Leader M: C-erbB-2 immunostaining: problems with interpretation. J Clin Pathol 47: 816-822, 1994.
22. Szollosi J, Balazs M, Feuerstein BG, Benz CC and Waldman FM: ERBB-2 (HER-2/neu) gene copy number, p185HER-2 over-expression, and intratumor heterogeneity in human breast cancer. Cancer Res 55: 5400-5407, 1995.
23. Gramlich TL, Cohen C, Fritsch C, DeRose PB and Gansler T: Evaluation of c-erbB-2 amplification in breast carcinoma by differential polymerase chain reaction. Am J Clin Pathol 101: 493-499, 1994.
24. Kallioniemi OP, Kallioniemi A, Kurisu W, Thor A, Chen LC, Smith HS, Waldman FM, Pinkel D and Gray JW: ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization. Proc. Natl. Acad. Sci. USA 89: 5321-5325, 1992.
25. Dugan MC, Dergham ST, Kucway R, Singh K, Biernat L, Du W, Vaitkevicius VK, Crissman JD and Sarkar FH: HER-2/neu expression in pancreatic adenocarcinoma: relation to tumor differentiation and survival. Pancreas 14: 229-236, 1997.
26. Neal DE, Marsh C, Bennett MK, Abel PD, Hall RR, Sainsbury JR, and Harris AL: Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumours. Lancet 1, 366-368, 1985.
27. Sainsbury JR, Malcolm AJ, Appleton DR, Farndon JR and Harris AL: Presence of epidermal growth factor receptor as an indicator of poor prognosis in patients with breast cancer. J Clin Pathol 38: 1225-1228, 1985.
28. Busmanis I, Feleppa F, Jones A, McGrath KM, Reed R, Collins J, Russell I and Begley CG: Analysis of cerbB2 expression using a panel of 6 commercially available antibodies. Pathology 26: 261-267, 1994.